A noninvasive method for predicting clinically significant prostate cancer using magnetic resonance imaging combined with PRKY promoter methylation level: a machine learning study

被引:0
作者
Yufei Wang
Weifeng Liu
Zeyu Chen
Yachen Zang
Lijun Xu
Zheng Dai
Yibin Zhou
Jin Zhu
机构
[1] The Second Affiliated Hospital of Soochow University,Department of Urology
[2] Hefei First People’s Hopital,Department of Urology
来源
BMC Medical Imaging | / 24卷
关键词
Radiomics; Clinically significant prostate cancer; PRKY promoter methylation; Machine learning;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 186 条
[1]  
Carlsson SV(2020)Screening for prostate cancer Med Clin North Am 104 1051-1062
[2]  
Vickers AJ(2022)Should Grade Group 1 (GG1) be called cancer? World J Urol 40 15-19
[3]  
Labbate CV(2019)Are Prostate Specific-Antigen (PSA) and age associated with the risk of ISUP Grade 1 prostate cancer? Results from 72 996 individual biopsy cores in 6 083 men from the Stockholm3 study PLoS One 14 e0218280-62
[4]  
Paner GP(2021)EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent Eur Urol 79 243-1775
[5]  
Eggener SE(2008)Practice guideline ’Prostate cancer: diagnosis and treatment’ Ned Tijdschr Geneeskd 152 1771-553
[6]  
Palsdottir T(2014)Pain during transrectal ultrasound-guided prostate biopsy and the role of periprostatic nerve block: what radiologists should know Korean J Radiol 15 543-365
[7]  
Nordström T(2017)Complications after systematic, random, and image-guided prostate biopsy Eur Urol 71 353-463
[8]  
Aly M(1993)Multiple transrectal ultrasound-guided prostatic biopsies–true morbidity and patient acceptance Br J Urol 71 460-610
[9]  
Lindberg J(1997)Patient tolerance of transrectal ultrasound-guided biopsy of the prostate Br J Urol 79 608-892
[10]  
Clements M(2013)Systematic review of complications of prostate biopsy Eur Urol 64 876-52